Market capitalization | MXN808.71b |
Enterprise Value | MXN890.96b |
P/E (TTM) P/E ratio | 11.14 |
EV/FCF (TTM) EV/FCF | 7.67 |
EV/Sales (TTM) EV/Sales | 2.81 |
P/S ratio (TTM) P/S ratio | 2.55 |
P/B ratio (TTM) P/B ratio | 1.83 |
Dividend yield | 4.43% |
Last dividend (FY24) | MXN4.60 |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
16 Analysts have issued a Grupo Mexico forecast:
16 Analysts have issued a Grupo Mexico forecast:
Mar '25 |
+/-
%
|
||
Revenue | 316,917 316,917 |
28%
28%
|
|
Gross Profit | 146,952 146,952 |
41%
41%
|
|
EBITDA | 165,294 165,294 |
37%
37%
|
EBIT (Operating Income) EBIT | 140,277 140,277 |
42%
42%
|
Net Profit | 70,899 70,899 |
27%
27%
|
In millions MXN.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Grupo México S.A.B. de C.V. engages in the provision of copper business. The firm’s activities include mining, exploration, exploitation and freight railroad service and infrastructure development. It operates through the following divisions: Mining, Transportation, Infrastructure and Corporate. The Mining division includes copper extraction, copper smelting and refining operations, copper production, with byproducts of molybdenum, silver and other materials, mainly in Peru and the USA. The Transportation division provides rail transportation operations carried out through its subsidiaries. The Infrastructure division carries out activities such as provision of oil drilling services, construction services and construction of power generation plants. The Corporate division represents the balances and corporate transactions that originate from activities carried out in the US, Peru and Mexico. The company was founded in 1942 and is headquartered in Mexico City, Mexico.
Head office | Mexico |
CEO | Germán Mota-Velasco |
Employees | 31,523 |
Founded | 1942 |
Website | www.gmexico.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.